NCT03240692View on ClinicalTrials.gov

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression: OL Cohort

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

March 3, 2020

Conditions
Treatment Resistant Depression
Interventions
DEVICE

Accelerated theta-burst stimulation treatment

"All participants will receive intermittent theta-burst stimulation (iTBS) to the left dorsal lateral prefrontal cortex (L-DLPFC). The L-DLPFC will be targeted utilizing the Localite neuronavigation system. Stimulation intensity will be standardized at 90% of resting motor threshold (adjusted for cortical depth).~Stimulation will be delivered to L-DLPFC using the Magventure Magpro X100 and/or the NextStim TMS system."

Trial Locations (1)

94305

Nolan Williams, MD, Palo Alto

All Listed Sponsors
collaborator

Schatzberg, Alan, M.D.

INDIV

lead

Stanford University

OTHER

NCT03240692 - Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression: OL Cohort | Biotech Hunter | Biotech Hunter